Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses
Jack Phan(The University of Texas MD Anderson Cancer Center), Steven J. Frank(The University of Texas MD Anderson Cancer Center), Theresa Nguyen(The University of Texas MD Anderson Cancer Center), Michael E. Kupferman(The University of Texas MD Anderson Cancer Center), Mark Zafereo(Texas Medical Center), G. Brandon Gunn(The University of Texas MD Anderson Cancer Center), David I. Rosenthal(The University of Texas MD Anderson Cancer Center), Terence T. Sio(The University of Texas MD Anderson Cancer Center), Vinita Takiar(University of Cincinnati), Clifton D. Fuller(The University of Texas MD Anderson Cancer Center), Adam S. Garden(The University of Texas MD Anderson Cancer Center), Beth M. Beadle(Stanford University), William N. William(The University of Texas MD Anderson Cancer Center), Dominic Ma(The University of Texas MD Anderson Cancer Center), William H. Morrison(The University of Texas MD Anderson Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
April 13, 2016
Cited by 149
Related Papers
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
|The Lancet Oncology|2016|1.1k
The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation
|International Journal of Radiation Oncology*Biology*Physics|1995|458
Management of Salivary Gland Malignancy: ASCO Guideline
|Journal of Clinical Oncology|2021|401
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
|Radiotherapy and Oncology|2017|374